Search results for "Highlights"


 
Results 81 - 90 of about 224 for "Highlights".
Sort by: Relevance | Newest | Oldest

ACG updates its guideline on acute lower GI bleeding

The American College of Gastroenterology (ACG) now recommends risk stratification to identify patients who can be discharged early and advises on the use of anticoagulant reversal agents, among other changes.
https://gastroenterology.acponline.org/archives/2023/03/24/2.htm
24 Mar 2023

Beta-blockers linked to better outcomes in some patients with cirrhosis

Decompensation-free survival improved in patients with cirrhosis and portal hypertension who received beta-blockers versus placebo, largely due to a decrease in ascites.
https://gastroenterology.acponline.org/archives/2019/04/26/3.htm
26 Apr 2019

Spotlight on esophageal adenocarcinoma

High-dose proton-pump inhibitors and aspirin appeared effective for chemoprevention in patients with Barrett's esophagus in one study, while another study found a positive association between human papillomavirus status and survival in patients with Barrett's high-grade dysplasia and esophageal adenocarcinoma.
https://gastroenterology.acponline.org/archives/2018/08/24/5.htm
24 Aug 2018

More concentrated care linked to adverse outcomes in patients with cirrhosis

A retrospective cohort study looked at patients with cirrhosis who were enrolled in Medicare and had had more than four outpatient visits over 180 days.
https://gastroenterology.acponline.org/archives/2020/01/24/2.htm
24 Jan 2020

DPP-4 inhibitors associated with risk of cholecystitis, meta-analysis finds

Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
https://gastroenterology.acponline.org/archives/2022/07/22/6.htm
22 Jul 2022

Noninvasive methods as good as biopsy for NAFLD prognosis, meta-analysis finds

An analysis of patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD) compared the prognostic value of liver stiffness measured by vibration-controlled transient elastography, fibrosis-4 index, and NAFLD fibrosis score.
https://gastroenterology.acponline.org/archives/2023/06/23/1.htm
23 Jun 2023

ACIP updates hepatitis A vaccination recommendations

The Advisory Committee on Immunization Practices (ACIP) changed its recommendations regarding vaccination of patients with chronic liver disease, pregnant women, and those treated with blood products for clotting disorders, among other revisions.
https://gastroenterology.acponline.org/archives/2020/07/24/1.htm
24 Jul 2020

Guidance issued on pharmacologic treatment of chronic idiopathic constipation

The joint clinical practice guideline from the American Gastroenterological Association and the American College of Gastroenterology reviewed evidence on fiber, osmotic laxatives, stimulant laxatives, secretagogues, and a serotonin type 4 agonist.
https://gastroenterology.acponline.org/archives/2023/05/26/1.htm
26 May 2023

Colonoscopy surveillance every 3 years may be sufficient after polypectomy

A multicenter randomized trial in Japan found that a single surveillance colonoscopy three years postpolypectomy and two surveillance colonoscopies at one and three years were similarly accurate for detecting clinically important neoplastic lesions.
https://gastroenterology.acponline.org/archives/2020/11/20/2.htm
20 Nov 2020

Halting one ulcerative colitis treatment after escalating to new drug may be feasible, study finds

Patients with ulcerative colitis treated with 5-aminosalicylates who require escalation to anti-tumor necrosis factor-alpha (anti-TNF) therapy may be able to safely discontinue the first drug.
https://gastroenterology.acponline.org/archives/2018/11/27/3.htm
27 Nov 2018

Result Page: Prev   4   5   6   7   8   9   10   11   12   13   Next